FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072228651> ?p ?o ?g. }

• W2072228651 endingPage "S15" @default.
• W2072228651 startingPage "S8" @default.
• W2072228651 abstract "The presence of estrogen receptors (ERs), as detected by immunohistochemistry (IHC), is a weak prognostic marker of clinical outcome in breast cancer, but a strong predictive marker for response, for example, to tamoxifen-based therapy. As with all IHC markers, factors such as tissue fixation (both type and duration), the choice of antibody, and the threshold for interpretation of positive immunostaining can dramatically affect test accuracy and reproducibility. For example, optimal fixation for detection of ER requires at least 6–8 h in formalin, and the use of newer antibodies such as SP1 may identify additional patients who might benefit from hormonal therapy. Although the threshold for positivity may be as few as 1% of tumor cells showing nuclear signal, recent studies appear to demonstrate a dichotomization of ER IHC, with the vast majority of cases showing all positive or all negative results. This may be helpful in dictating the appropriateness of hormonal therapy, but quantification of ER by IHC, or other methods, may play a more important role in the future. Breast cancers with human epidermal receptor protein-2 (c-erbB-2; HER2) alterations are critical to identify because such tumors require unique treatment, including the use of targeted therapies such as trastuzumab. HER2 alterations at the DNA (amplification) and protein (overexpression) level usually occur in concert, and both fluorescence in situ hybridization (FISH) or IHC can be accurate methods to assess these alterations. However, recent studies have suggested that serious reproducibility issues exist in both FISH and IHC HER2 studies. To address this, a joint committee of both the American Society for Clinical Oncologists and the College of American Pathologists has promulgated new guidelines for HER2 testing. These include the following: (a) recommendations for tissue fixation for more than 6 and less than 48 h; (b) new scoring criteria, including a new threshold of 30% strong immunostaining for classification of 3+; (c) introduction of the term ‘equivocal’ to characterize HER2 studies that are 2+ by IHC and/or show HER2/chromosome 17 ratios of between 1.8 and 2.2 by FISH; (d) requirements for laboratories to validate HER2 assays, generally through the cross-testing of cases with another HER2 methodology, with laboratories required to attain 95% concordance for both positive and negative tests; (e) participation in HER2 proficiency testing." @default.
• W2072228651 created "2016-06-24" @default.
• W2072228651 creator A5080534060 @default.
• W2072228651 date "2008-05-01" @default.
• W2072228651 modified "2023-10-18" @default.
• W2072228651 title "Current issues in ER and HER2 testing by IHC in breast cancer" @default.
• W2072228651 cites W1772131958 @default.
• W2072228651 cites W1829077072 @default.
• W2072228651 cites W1837870834 @default.
• W2072228651 cites W1867197625 @default.
• W2072228651 cites W1884767706 @default.
• W2072228651 cites W1892496998 @default.
• W2072228651 cites W1898692666 @default.
• W2072228651 cites W1971026364 @default.
• W2072228651 cites W1976052438 @default.
• W2072228651 cites W1986314326 @default.
• W2072228651 cites W1999329028 @default.
• W2072228651 cites W1999368908 @default.
• W2072228651 cites W2015435732 @default.
• W2072228651 cites W2017238868 @default.
• W2072228651 cites W2021772925 @default.
• W2072228651 cites W2031473351 @default.
• W2072228651 cites W2037392079 @default.
• W2072228651 cites W2039634875 @default.
• W2072228651 cites W2044791827 @default.
• W2072228651 cites W2048686497 @default.
• W2072228651 cites W2056182801 @default.
• W2072228651 cites W2064347883 @default.
• W2072228651 cites W2067199269 @default.
• W2072228651 cites W2077266258 @default.
• W2072228651 cites W2077486811 @default.
• W2072228651 cites W2077560541 @default.
• W2072228651 cites W2078881615 @default.
• W2072228651 cites W2082165791 @default.
• W2072228651 cites W2095156669 @default.
• W2072228651 cites W2095950656 @default.
• W2072228651 cites W2096881573 @default.
• W2072228651 cites W2099630695 @default.
• W2072228651 cites W2100375606 @default.
• W2072228651 cites W2104528117 @default.
• W2072228651 cites W2104872563 @default.
• W2072228651 cites W2107413762 @default.
• W2072228651 cites W2110444464 @default.
• W2072228651 cites W2118343282 @default.
• W2072228651 cites W2119776650 @default.
• W2072228651 cites W2123179063 @default.
• W2072228651 cites W2125730396 @default.
• W2072228651 cites W2126816162 @default.
• W2072228651 cites W2130900820 @default.
• W2072228651 cites W2132039396 @default.
• W2072228651 cites W2143955162 @default.
• W2072228651 cites W2146384083 @default.
• W2072228651 cites W2147844426 @default.
• W2072228651 cites W2149908785 @default.
• W2072228651 cites W2152494192 @default.
• W2072228651 cites W2156544288 @default.
• W2072228651 cites W2159459001 @default.
• W2072228651 cites W2164792647 @default.
• W2072228651 cites W2168631900 @default.
• W2072228651 cites W2168658644 @default.
• W2072228651 cites W2169577449 @default.
• W2072228651 cites W2288763477 @default.
• W2072228651 cites W2291927913 @default.
• W2072228651 cites W2322214717 @default.
• W2072228651 cites W2333684590 @default.
• W2072228651 cites W2601483084 @default.
• W2072228651 cites W3128877721 @default.
• W2072228651 cites W4239989216 @default.
• W2072228651 cites W4246256927 @default.
• W2072228651 cites W4295254191 @default.
• W2072228651 doi "https://doi.org/10.1038/modpathol.2008.34" @default.
• W2072228651 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18437174" @default.
• W2072228651 hasPublicationYear "2008" @default.
• W2072228651 type Work @default.
• W2072228651 sameAs 2072228651 @default.
• W2072228651 citedByCount "321" @default.
• W2072228651 countsByYear W20722286512012 @default.
• W2072228651 countsByYear W20722286512013 @default.
• W2072228651 countsByYear W20722286512014 @default.
• W2072228651 countsByYear W20722286512015 @default.
• W2072228651 countsByYear W20722286512016 @default.
• W2072228651 countsByYear W20722286512017 @default.
• W2072228651 countsByYear W20722286512018 @default.
• W2072228651 countsByYear W20722286512019 @default.
• W2072228651 countsByYear W20722286512020 @default.
• W2072228651 countsByYear W20722286512021 @default.
• W2072228651 countsByYear W20722286512022 @default.
• W2072228651 countsByYear W20722286512023 @default.
• W2072228651 crossrefType "journal-article" @default.
• W2072228651 hasAuthorship W2072228651A5080534060 @default.
• W2072228651 hasBestOaLocation W20722286511 @default.
• W2072228651 hasConcept C104317684 @default.
• W2072228651 hasConcept C121608353 @default.
• W2072228651 hasConcept C126322002 @default.
• W2072228651 hasConcept C142724271 @default.
• W2072228651 hasConcept C143998085 @default.
• W2072228651 hasConcept C204232928 @default.
• W2072228651 hasConcept C2777176818 @default.

• next